Human EPHB4 (Eph receptor B4/HTK) knockout HEK-293T cell lysate

Description

Knockout cell lysate achieved by CRISPR/Cas9. REACH authorisation Abcam has not and does not intend to apply for the REACH Authorisation of customers uses of products that contain European Authorisation list Annex XIV substances. It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses. Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail ratio: 300:100:10 . This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared. User storage instructions: Lyophilizate may be stored at 4C. After reconstitution, store at -20C for short-term storage or -80C for long-term storage. This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.